Related references
Note: Only part of the references are listed.Lithium Treatment Arrests the Development of Neurofibrillary Tangles in Mutant Tau Transgenic Mice with Advanced Neurofibrillary Pathology
Karelle Leroy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid beta After a Single Administration of an Amyloid beta Monoclonal Antibody in Subjects With Alzheimer Disease
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting β-Amyloid
V. Frisardi et al.
CURRENT ALZHEIMER RESEARCH (2010)
Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles?
Stacey Fuller et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Oxidative stress in Alzheimer disease: A possibility for prevention
David J. Bonda et al.
NEUROPHARMACOLOGY (2010)
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review
Dimitris Repantis et al.
PHARMACOLOGICAL RESEARCH (2010)
Resveratrol: Its Biologic Targets and Functional Activity
Shazib Pervaiz et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Recent developments in Alzheimer's disease therapeutics
Michael S. Rafii et al.
BMC MEDICINE (2009)
Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils
Silvia Lorrio et al.
BRAIN RESEARCH (2009)
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)
Tauheed Ishrat et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
Joanne Rodda et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Why Did Tarenflurbil Fail in Alzheimer's Disease?
Bruno P. Imbimbo
JOURNAL OF ALZHEIMERS DISEASE (2009)
What we have learned from the xaliproden Sanofi-aventis trials
P. Douillet et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Antioxidant, Free Radical-Scavenging, and NF-κB-Inhibitory Activities of Phytosteryl Ferulates: Structure-Activity Studies
Md. Shafiqul Islam et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment
Sunil Kumar Hota et al.
NEUROBIOLOGY OF DISEASE (2009)
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
Saravanan S. Karuppagounder et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats
Vinod Tiwari et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Suppression of NF-κβ signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits
Anurag Kuhad et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Donepezil Improves Episodic Memory in Young Individuals Vulnerable to the Effects of Sleep Deprivation
Lisa Y. M. Chuah et al.
SLEEP (2009)
Current approaches in the treatment of Alzheimer's disease
Reena S. Shah et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
Kavon Rezai-Zadeh et al.
BRAIN RESEARCH (2008)
Protective effects of vitamin E and curcumin on L-thyroxine-induced rat testicular oxidative stress
Dipak Kumar Sahoo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways
Hani Atamna et al.
FASEB JOURNAL (2008)
Current and future therapy in Alzheimer's disease
Robert J. van Marum
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms
Manjeet Singh et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Green tea catechins prevent cognitive deficits caused by Aβ1-40 in rats
Abdul M. Haque et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease
Yasuji Matsuoka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain:: Inverse correlation with Aβ levels
E. Hellstrom-Lindahl et al.
NEUROBIOLOGY OF AGING (2008)
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
George J. Siegel et al.
NEUROLOGY (2008)
Ferulic acid attenuated cognitive deficits and increase in carbonyl proteins induced by buthionine-sulfoximine in mice
Takayoshi Mamiya et al.
NEUROSCIENCE LETTERS (2008)
Inhibition and modulation of γ-secretase for Alzheimer's disease
Michael S. Wolfe
NEUROTHERAPEUTICS (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Alzheimer's disease; taking the edge off with cannabinoids?
V. A. Campbell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences
Anurag Kuhad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia
Eduardo Candelario-Jalil et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Hormone therapy in menopausal women with cognitive complaints - A randomized, double-blind trial
P. M. Maki et al.
NEUROLOGY (2007)
Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)
Santosh K. Sandur et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat
Meherzia Mokni et al.
NEUROCHEMICAL RESEARCH (2007)
Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells
Na Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element
Toru Nishinaka et al.
TOXICOLOGY LETTERS (2007)
Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers
David Butler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Increases in luteinizing hormone are associated with declines in cognitive performance
Gemma Casadesus et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
Matthew L. Hemming et al.
NEUROBIOLOGY OF DISEASE (2007)
Neuroprotection by resveratrol against traumatic brain injury in rats
Ozkan Ates et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Regulation of inflammation and redox signaling by dietary polyphenols
Irfan Rahman et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer's disease
Jun Wang et al.
FASEB JOURNAL (2006)
ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease:: OmegAD study -: A randomized double-blind trial
Yvonne Freund-Levi et al.
ARCHIVES OF NEUROLOGY (2006)
What constitutes clinical evidence for neuroprotection in Alzheimer disease - Support for the cholinesterase inhibitors?
E Mori et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders
S Mandel et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
RM Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
M Sastre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
alpha-secretase activation - An approach to Alzheimer's disease therapy
Falk Fahrenholz et al.
NEURODEGENERATIVE DISEASES (2006)
Curcumin, an atoxic antioxidant and natural NF kappa B, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases
Stig Bengmark
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2006)
Anti-amyloidogenic effects of antioxidants: Implications for the prevention and therapeutics of Alzheimer's disease
Kenjiro Ono et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues
QY Wei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides
P Marambaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pathophysiology of Alzheimer's disease
BP Imbimbo et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation
T Saito et al.
NATURE MEDICINE (2005)
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
Antioxidant effect of ferulic acid in isolated membranes and intact cells:: Synergistic interactions with α-tocopherol, β-carotene, and ascorbic acid
S Trombino et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Strategies for disease modification in Alzheimer's disease
M Citron
NATURE REVIEWS NEUROSCIENCE (2004)
Metal and inflammatory targets for Alzheimer's disease
JT Rogers et al.
CURRENT DRUG TARGETS (2004)
Metal-protein attenuating compounds and Alzheimers disease
CW Ritchie et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
A Dedeoglu et al.
EXPERIMENTAL GERONTOLOGY (2004)
Combination therapy in Alzheimer's disease - A review of current evidence
B Schmitt et al.
CNS DRUGS (2004)
Molecular basis of vitamin E action - Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration
S Khanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Current treatment for Alzheimer disease and future prospects
PN Tariot et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2003)
Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme
EA Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients
E Mulugeta et al.
BRAIN RESEARCH (2003)
M-1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease - Implications in future therapy
A Fisher et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
The role of insulin resistance in the pathogenesis of Alzheimer's disease - Implications for treatment
GS Watson et al.
CNS DRUGS (2003)
Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells
J Choi et al.
PROTEOMICS (2003)
A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba -: Anticholinesterase and cognitive enhancing activities
A Das et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action
Y Levites et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Panax ginseng - A systematic review of adverse effects and drug interactions
JT Coon et al.
DRUG SAFETY (2002)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
Share Paper
